We’ve gathered some key stories from the GLP1 ecosystem in the last week you might have missed:
🤰 Research review on GLP1s during pregnancy
🏛️ Compounding pharmacy loses in court to Eli Lilly and Novo Nordisk
📈 GLP1 market update, by way of Eli Lilly quarterly earnings report
🚨 To date, over 80 deaths linked to GLP1s in the UK, over 150 in the US
🔓 Extra headline only for subscribers
🔓 Extra headline only for subscribers
🔓 Extra headline only for subscribers
🔓 Extra headline only for subscribers
Don’t have time to read it all? GLP1.Guide supporters get our summaries and analysis below 👇
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.